FDA Approves Gene Therapy for Ultra-Rare Immune Disease

Children born with a life-threatening immune disorder now have hope thanks to a newly approved gene therapy that could save their lives with a single treatment.

The FDA just greenlit Kresladi, a breakthrough for severe LAD-1 that leaves kids defenseless against infections.